Drouet L - Search Results

1

[Fibrinogen: factor and marker of cardiovascular risk].

Drouet L, Bal Dit Sollier C. Drouet L, et al. J Mal Vasc. 2002 Jun;27(3):143-56. J Mal Vasc. 2002. PMID: 12232531 Review. French.

2

[Is fibrinogen a predictor or a marker of the risk of cardiovascular events?].

Drouet L, Bal dit Sollier C. Drouet L, et al. Therapie. 2005 Mar-Apr;60(2):125-36. doi: 10.2515/therapie:2005017. Therapie. 2005. PMID: 15969315 Review. French.

3

[Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].

Drouet L, Bal dit Sollier C. Drouet L, et al. Therapie. 2005 Mar-Apr;60(2):137-47. doi: 10.2515/therapie:2005018. Therapie. 2005. PMID: 15969316 Review. French.

4

Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?

Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E, Bal dit Sollier C, Vanhove N. Drouet L, et al. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S35-9. Blood Coagul Fibrinolysis. 1999. PMID: 10070816 Review. No abstract available.

5

[The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].

Drouet L, Bal dit Sollier C, Henry P. Drouet L, et al. Drugs. 2010 Nov 1;70 Suppl 1:9-14. doi: 10.2165/00000005-000000000-00000. Drugs. 2010. PMID: 20977287 Review. Japanese.

6

Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men.

Chironi G, Dosquet C, Del-Pino M, Denarie N, Megnien JL, Drouet L, Bal dit Sollier C, Levenson J, Simon A. Chironi G, et al. Among authors: drouet l. Am J Hypertens. 2006 Oct;19(10):1025-31. doi: 10.1016/j.amjhyper.2006.03.016. Am J Hypertens. 2006. PMID: 17027822

7

Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model.

Hainaud P, Brouland JP, André P, Simoneau G, Bal Dit Sollier C, Drouet L, Caen J, Bellucci S. Hainaud P, et al. Among authors: drouet l. Br J Haematol. 2002 Dec;119(4):998-1004. doi: 10.1046/j.1365-2141.2002.03966.x. Br J Haematol. 2002. PMID: 12472580 Free article.

8

Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.

André P, Brouland JP, Roussi J, Bonneau M, Pignaud G, Bal dit Sollier C, Hainaud P, Vaiman M, Drouet L. André P, et al. Among authors: drouet l. Exp Hematol. 1998 Jul;26(7):620-6. Exp Hematol. 1998. PMID: 9657137

9

Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease.

Roussi J, Turecek PL, André P, Bonneau M, Pignaud G, Bal dit Sollier C, Schlokat U, Dorner F, Schwarz HP, Drouet L. Roussi J, et al. Among authors: drouet l. Blood Coagul Fibrinolysis. 1998 Jun;9(4):361-72. doi: 10.1097/00001721-199806000-00009. Blood Coagul Fibrinolysis. 1998. PMID: 9690808

10

[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].

Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L. Drouet L, et al. Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:41-51. Arch Mal Coeur Vaiss. 1998. PMID: 9833079 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters